1120203

LEC Custom Products, Inc. — FEI 3004737602

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 6, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brampton (Canada)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
104921 CFR 211.22(a)Approve or reject components, products
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
137121 CFR 211.101(a)Batches Formulated to less than 100%
139521 CFR 211.103Actual vs. theoretical yields not determined
177721 CFR 211.150(b)Distribution Recall System
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
179621 CFR 211.80(d)Identification of Each Lot in Each Shipment
180921 CFR 211.160(a)Following/documenting laboratory controls
191421 CFR 211.166(a)Lack of written stability program
197521 CFR 211.182Written records kept in individual logs
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
202321 CFR 211.188(b)(11)Identification of Persons Performing Significant Steps
357321 CFR 211.101(b)Measured components for manufacturing
358321 CFR 211.110(a)Written in-process control procedures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
430721 CFR 211.80(d)Status of Each Lot Identified
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
438921 CFR 211.198(a)Procedures to be written and followed
900121 CFR 211.22(a)Lack of quality control unit